Global Regenerative Medicine Market Size, Status, Research and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 108

Report ID: 9415

Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the "process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function". It is through the use of innovative medical means rebuilding diseased or damaged tissue or to support diseased or damaged tissue regeneration. The methods used include cell therapy, tissue engineering, chemically induced and therapeutic cloning, etc. Any combination of these technologies may be used to harness or stimulate the body’s innate healing ability in order to treat a wide range of ailments, including musculoskeletal-related conditions, cardio- and peripheral vascular diseases, neurological disorders, stroke, non-healing wounds and ocular diseases.
Currently, some companies in the world can provide regenerative medicine service, mainly concentrating in USA. The main market players are DePuy Synthes, Medtronic, ZimmerBiomet, Stryker, Acelity, MiMedx Group, Organogenesis, UniQure, Cellular Dynamics International, etc.

USA is the largest market of regenerative medicine, which occupies 51.09 percent of global regenerative medicine market share in 2015. It is followed by EU, which has around 16.66 percent of the global total industry. Other main regions which take important part in this industry include Japan and China.

According to the research, the most potential market in the main countries of regenerative medicine industry is Asia, determined by the rising level of medical care. Besides, South America, Middle East should also be focused by the investors. They are the potential consumers of regenerative medicine.

Despite the presence of competition problems, due to the huge industry profits, investors are still optimistic about this area; there will be more investments to enter the field.

The relatively-mature technology is cell transplantation; tissue engineering and therapeutic cloning has its technical advantages, which is the direction of future research and development.


In 2018, the global Regenerative Medicine market size was 5350 million US$ and it is expected to reach 28800 million US$ by the end of 2025, with a CAGR of 23.4% during 2019-2025.

This report focuses on the global Regenerative Medicine status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Regenerative Medicine development in United States, Europe and China.

The key players covered in this study
DePuy Synthes
Medtronic
ZimmerBiomet
Stryker
Acelity
MiMedx Group
Organogenesis
UniQure
Cellular Dynamics International
Osiris Therapeutics
Vcanbio
Gamida Cell
Golden Meditech
Cytori
Celgene
Vericel Corporation
Guanhao Biotech
Mesoblast
Stemcell Technologies
Bellicum Pharmaceuticals

Market segment by Type, the product can be split into
Cell Therapy
Tissue Engineering
Biomaterial
Other

Market segment by Application, split into
Dermatology
Cardiovascular
CNS
Orthopedic
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Regenerative Medicine status, future forecast, growth opportunity, key market and key players.
To present the Regenerative Medicine development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Regenerative Medicine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Regenerative Medicine Market Size Growth Rate by Type (2014-2025)
1.4.2 Cell Therapy
1.4.3 Tissue Engineering
1.4.4 Biomaterial
1.4.5 Other
1.5 Market by Application
1.5.1 Global Regenerative Medicine Market Share by Application (2014-2025)
1.5.2 Dermatology
1.5.3 Cardiovascular
1.5.4 CNS
1.5.5 Orthopedic
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Regenerative Medicine Market Size
2.2 Regenerative Medicine Growth Trends by Regions
2.2.1 Regenerative Medicine Market Size by Regions (2014-2025)
2.2.2 Regenerative Medicine Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Regenerative Medicine Market Size by Manufacturers
3.1.1 Global Regenerative Medicine Revenue by Manufacturers (2014-2019)
3.1.2 Global Regenerative Medicine Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Regenerative Medicine Market Concentration Ratio (CR5 and HHI)
3.2 Regenerative Medicine Key Players Head office and Area Served
3.3 Key Players Regenerative Medicine Product/Solution/Service
3.4 Date of Enter into Regenerative Medicine Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Regenerative Medicine Market Size by Type (2014-2019)
4.2 Global Regenerative Medicine Market Size by Application (2014-2019)

5 United States
5.1 United States Regenerative Medicine Market Size (2014-2019)
5.2 Regenerative Medicine Key Players in United States
5.3 United States Regenerative Medicine Market Size by Type
5.4 United States Regenerative Medicine Market Size by Application

6 Europe
6.1 Europe Regenerative Medicine Market Size (2014-2019)
6.2 Regenerative Medicine Key Players in Europe
6.3 Europe Regenerative Medicine Market Size by Type
6.4 Europe Regenerative Medicine Market Size by Application

7 China
7.1 China Regenerative Medicine Market Size (2014-2019)
7.2 Regenerative Medicine Key Players in China
7.3 China Regenerative Medicine Market Size by Type
7.4 China Regenerative Medicine Market Size by Application

8 Japan
8.1 Japan Regenerative Medicine Market Size (2014-2019)
8.2 Regenerative Medicine Key Players in Japan
8.3 Japan Regenerative Medicine Market Size by Type
8.4 Japan Regenerative Medicine Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Regenerative Medicine Market Size (2014-2019)
9.2 Regenerative Medicine Key Players in Southeast Asia
9.3 Southeast Asia Regenerative Medicine Market Size by Type
9.4 Southeast Asia Regenerative Medicine Market Size by Application

10 India
10.1 India Regenerative Medicine Market Size (2014-2019)
10.2 Regenerative Medicine Key Players in India
10.3 India Regenerative Medicine Market Size by Type
10.4 India Regenerative Medicine Market Size by Application

11 Central & South America
11.1 Central & South America Regenerative Medicine Market Size (2014-2019)
11.2 Regenerative Medicine Key Players in Central & South America
11.3 Central & South America Regenerative Medicine Market Size by Type
11.4 Central & South America Regenerative Medicine Market Size by Application

12 International Players Profiles
12.1 DePuy Synthes
12.1.1 DePuy Synthes Company Details
12.1.2 Company Description and Business Overview
12.1.3 Regenerative Medicine Introduction
12.1.4 DePuy Synthes Revenue in Regenerative Medicine Business (2014-2019)
12.1.5 DePuy Synthes Recent Development
12.2 Medtronic
12.2.1 Medtronic Company Details
12.2.2 Company Description and Business Overview
12.2.3 Regenerative Medicine Introduction
12.2.4 Medtronic Revenue in Regenerative Medicine Business (2014-2019)
12.2.5 Medtronic Recent Development
12.3 ZimmerBiomet
12.3.1 ZimmerBiomet Company Details
12.3.2 Company Description and Business Overview
12.3.3 Regenerative Medicine Introduction
12.3.4 ZimmerBiomet Revenue in Regenerative Medicine Business (2014-2019)
12.3.5 ZimmerBiomet Recent Development
12.4 Stryker
12.4.1 Stryker Company Details
12.4.2 Company Description and Business Overview
12.4.3 Regenerative Medicine Introduction
12.4.4 Stryker Revenue in Regenerative Medicine Business (2014-2019)
12.4.5 Stryker Recent Development
12.5 Acelity
12.5.1 Acelity Company Details
12.5.2 Company Description and Business Overview
12.5.3 Regenerative Medicine Introduction
12.5.4 Acelity Revenue in Regenerative Medicine Business (2014-2019)
12.5.5 Acelity Recent Development
12.6 MiMedx Group
12.6.1 MiMedx Group Company Details
12.6.2 Company Description and Business Overview
12.6.3 Regenerative Medicine Introduction
12.6.4 MiMedx Group Revenue in Regenerative Medicine Business (2014-2019)
12.6.5 MiMedx Group Recent Development
12.7 Organogenesis
12.7.1 Organogenesis Company Details
12.7.2 Company Description and Business Overview
12.7.3 Regenerative Medicine Introduction
12.7.4 Organogenesis Revenue in Regenerative Medicine Business (2014-2019)
12.7.5 Organogenesis Recent Development
12.8 UniQure
12.8.1 UniQure Company Details
12.8.2 Company Description and Business Overview
12.8.3 Regenerative Medicine Introduction
12.8.4 UniQure Revenue in Regenerative Medicine Business (2014-2019)
12.8.5 UniQure Recent Development
12.9 Cellular Dynamics International
12.9.1 Cellular Dynamics International Company Details
12.9.2 Company Description and Business Overview
12.9.3 Regenerative Medicine Introduction
12.9.4 Cellular Dynamics International Revenue in Regenerative Medicine Business (2014-2019)
12.9.5 Cellular Dynamics International Recent Development
12.10 Osiris Therapeutics
12.10.1 Osiris Therapeutics Company Details
12.10.2 Company Description and Business Overview
12.10.3 Regenerative Medicine Introduction
12.10.4 Osiris Therapeutics Revenue in Regenerative Medicine Business (2014-2019)
12.10.5 Osiris Therapeutics Recent Development
12.11 Vcanbio
12.12 Gamida Cell
12.13 Golden Meditech
12.14 Cytori
12.15 Celgene
12.16 Vericel Corporation
12.17 Guanhao Biotech
12.18 Mesoblast
12.19 Stemcell Technologies
12.20 Bellicum Pharmaceuticals

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details